Order Article Reprints

Ruiz-Boy S, Pedraza A, Prat M, Salas MQ, Carcelero E, Riu-Viladoms G, Suárez-Lledó M, Monge-Escartín I, Rodríguez-Lobato LG, Martínez-Roca A, et al. At-Home Foscarnet Administration in Patients with Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: A Unicentric, Safe, and Feasible Program. Pharmaceuticals. 2023; 16(12):1741. https://doi.org/10.3390/ph16121741

Ruiz-Boy, Sonia, Alexandra Pedraza, Marta Prat, Maria Queralt Salas, Esther Carcelero, Gisela Riu-Viladoms, María Suárez-Lledó, Inés Monge-Escartín, Luis Gerardo Rodríguez-Lobato, Alexandra Martínez-Roca, and et al. 2023. "At-Home Foscarnet Administration in Patients with Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: A Unicentric, Safe, and Feasible Program" Pharmaceuticals 16, no. 12: 1741. https://doi.org/10.3390/ph16121741

Ruiz-Boy, S., Pedraza, A., Prat, M., Salas, M. Q., Carcelero, E., Riu-Viladoms, G., Suárez-Lledó, M., Monge-Escartín, I., Rodríguez-Lobato, L. G., Martínez-Roca, A., Rovira, M., Martínez, C., Gallego, C., Urbano-Ispizua, Á., Sánchez, J., Marcos, M. Á., & Fernández-Avilés, F. (2023). At-Home Foscarnet Administration in Patients with Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: A Unicentric, Safe, and Feasible Program. Pharmaceuticals, 16(12), 1741. https://doi.org/10.3390/ph16121741